XTL Biopharmaceuticals Sponsored ADR share price logo

XTL Biopharmaceuticals Sponsored ADR

NASDAQ: XTLB

$2.16

+0.03

(+1.41%)

as on

XTL Biopharmaceuticals Sponsored ADR Stock Performance

as on October 5, 2026 at 2:15 pm IST

  • Day's High

    $2.16
    $2.21

    2.31%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $2.01
    $10.28
    downward going graph

    6.94%

    Downside

    375.91%

    Upside

    downward going graph

XTL Biopharmaceuticals Sponsored ADR share price movements today

Previous Close
$2.13
Open
$2.17
Volume
1.0M
Market Cap
$5.3M
Day's Low - High
$2.16 - $2.21
52 Week Low - High
$2.01 - $10.28

XTL Biopharmaceuticals Sponsored ADR Historical Returns

1 Month Return
-14.62 %
3 Month Return
-20 %
1 Year Return
-54.04 %
3 Year Return
-40.51 %
5 Year Return
-87.23 %

XTL Biopharmaceuticals Sponsored ADR Stock Fundamentals & Key Indicators

Check XTL Biopharmaceuticals Sponsored ADR market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$5.3M

EPS (TTM)

-2.88

Dividend Yield

0.00%

PE Ratio (TTM)

-1

Industry PE ratio

-3.89

PEG Ratio

0.01

Return On Equity TTM

3654.49%

XTL Biopharmaceuticals Sponsored ADR vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of XTL Biopharmaceuticals Sponsored ADR with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
NA$5.3M-87.23%-1.00-436.56%0.00%
StrongBuy$44.3B637.21%-23.320.00%0.00%
Neutral$75.9B-42.79%-23.81-12.57%0.00%
StrongBuy$127.9B185.14%29.1486.04%0.00%
Buy$75.7B33.45%17.5584.86%0.50%

Stock Returns calculator for XTL Biopharmaceuticals Sponsored ADR Stock including INR - Dollar returns

The XTL Biopharmaceuticals Sponsored ADR stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

XTL Biopharmaceuticals Sponsored ADR investment value today

Current value as on today

₹49,883

Returns

-₹50,117

(-50.12%)

Returns from XTL Biopharmaceuticals Sponsored ADR Stock

-₹54,043 (-54.04%)

Dollar Impact

₹3,926 (+3.93%)

Indian Investors' Interest in XTL Biopharmaceuticals Sponsored ADR Stock

Search interest for XTL Biopharmaceuticals Sponsored ADR Stock has decreased by -69% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-69% versus previous 30 day period

XTL Biopharmaceuticals Sponsored ADR Quarterly Profit & Loss

All numbers in Millions USD

Sep 2022
Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Total Revenue
-
-
-
-
-
-
-
-
0
0
Gross Profit
-
-
-
-
-
-
-
-
0
0
Operating Income
0
0
0
0
0
0
0
0
0
0
EBITDA
0
0
0
0
0
0
0
0
0
0
Interest Expense
-
-
0
0
0
-
0
0
0
0
Depreciation
0
0
0
0
0
0
0
-
0
0
Income Before Tax
0
0
0
0
0
0
0
0
0
0
Income Tax Expense
-
-
-
-
-
-
-
-
-
0
Net Income
0
0
0
0
0
0
0
0
0
0
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
100.00%
-14.88%

XTL Biopharmaceuticals Sponsored ADR Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
-
0
-
Gross Profit
-
-
-
0
0
0
-
0
-
Operating Income
-1
0
0
0
-1
0
0
-2
-1
EBITDA
-1
0
-
0
-1
0
0
0
0
Interest Expense
0
0
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
-
Income Before Tax
0
2
-1
-2
0
-1
-1
-1
0
Income Tax Expense
-
0
0
-
-
-
-
0
-
Net Income
0
2
-1
0
0
-1
0
-1
-6
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.67%
0.00%

XTL Biopharmaceuticals Sponsored ADR Quarterly Cash Flow

All numbers in Millions USD

Sep 2022
Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Net Income
0
0
0
0
0
0
0
0
0
0
Operating Cash Flow
-
-
-
-
-
-
-
-
-
-
Investing Cash Flow
-
-
-
-
-
-
-
-
-
-
Financing Cash Flow
-
-
-
-
-
-
-
-
-
-
Change in Cash
0
0
0
0
0
-4
-
-
-
-

XTL Biopharmaceuticals Sponsored ADR Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
0
2
-1
-2
0
-1
-1
-1
-6
Operating Cash Flow
-1
0
0
0
-1
0
0
-1
-1
Investing Cash Flow
-2
0
2
0
0
0
0
0
0
Financing Cash Flow
4
-
-
-
0
-
-
1
0
Change in Cash
1
0
1
0
0
0
0
-1
0

Global Institutional Holdings in XTL Biopharmaceuticals Sponsored ADR

Check out the Institutions with significant holdings in XTL Biopharmaceuticals Sponsored ADR.

Funds
Holdings
Noked Israel Ltd
0.00%
UBS Group AG
0.00%
GAMMA Investing LLC
0.05%
UBS Group AG
0.01%
GAMMA Investing LLC
0.14%

Insights on XTL Biopharmaceuticals Sponsored ADR

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 566.9% return, outperforming this stock by 620.9%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 84.5% return, outperforming this stock by 125.0%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 year, XTLB stock has moved down by -54.0%

About XTL Biopharmaceuticals Sponsored ADR

XTL Biopharmaceuticals Ltd. is a biopharmaceutical firm dedicated to identifying and advancing novel drug therapies for autoimmune conditions. Its primary investigational compound, hCDR1, is poised to enter Phase II trials, specifically targeting systemic lupus erythematosus and Sjogren's syndrome. The company holds a crucial licensing agreement with Yeda Research and Development Company Limited, which grants rights for the research, development, and eventual commercialization of hCDR1 across multiple therapeutic indications. Originally established in 1993 as Xenograft Technologies Ltd., the company rebranded to XTL Biopharmaceuticals Ltd. in July 1995. It operates from its headquarters in Ramat Gan, Israel.
OrganisationXTL Biopharmaceuticals Sponsored ADR
Headquarters85 Medinat Hayehudim St., Herzliya, TA, 4676670, IL
IndustryBiotechnology
CEONoam Band

Key Management of XTL Biopharmaceuticals Sponsored ADR

Name

Title

Mr. Noam Band

CEO & Director

Mr. Segal Niv CPA

Chief Financial Officer

FAQs

What is XTL Biopharmaceuticals Sponsored ADR share price today?

XTL Biopharmaceuticals Sponsored ADR share price today is $2.16 as on at the close of the market. XTL Biopharmaceuticals Sponsored ADR share today touched a day high of $2.21 and a low of $2.16.

What is the 52 week high and 52 week low for XTL Biopharmaceuticals Sponsored ADR share?

XTL Biopharmaceuticals Sponsored ADR share touched a 52 week high of $10.28 on and a 52 week low of $2.01 on . XTL Biopharmaceuticals Sponsored ADR stock price today i.e. is closed at $2.16,which is 78.99% down from its 52 week high and 7.46% up from its 52 week low.

What is XTL Biopharmaceuticals Sponsored ADR's market capitalisation today?

XTL Biopharmaceuticals Sponsored ADR market capitalisation is $0.00T as on .

How to invest in XTL Biopharmaceuticals Sponsored ADR Stock (XTLB) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for XTL Biopharmaceuticals Sponsored ADR on INDmoney app. Click on Buy button.

What is the minimum amount required to buy XTL Biopharmaceuticals Sponsored ADR Stock (XTLB) from India?

Indian investors can start investing in XTL Biopharmaceuticals Sponsored ADR (XTLB) shares with as little as ₹96.300003051758 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹963.00 in XTL Biopharmaceuticals Sponsored ADR stock (as per the Rupee-Dollar exchange rate as on ). Based on XTL Biopharmaceuticals Sponsored ADR share’s latest price of $2.16 as on October 5, 2026 at 8:45 am IST, you will get 4.6296 shares of XTL Biopharmaceuticals Sponsored ADR. Learn more about fractional shares .

What are the returns that XTL Biopharmaceuticals Sponsored ADR has given to Indian investors in the last 5 years?

XTL Biopharmaceuticals Sponsored ADR stock has given -87.23% share price returns and 29.14% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?